Dendritic cells derived exosomes can more effectively stimulate CD4+ helper T cells and CD8+ CLTs proliferation and induce an anti-tumor immune response, representing a novel immunotherapy method for ovarian cancer patients85. This evidence concerns the gene CD8A and neoplasm.